O

Orion Oyj
OTC:ORINF

Watchlist Manager
Orion Oyj
OTC:ORINF
Watchlist
Price: 81.3 USD 67.11% Market Closed
Market Cap: 11.4B USD

Relative Value

The Relative Value of one ORINF stock under the Base Case scenario is hidden USD. Compared to the current market price of 81.3 USD, Orion Oyj is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ORINF Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
25
Median 3Y
4.8
Median 5Y
4.6
Industry
2.7
Forward
5.2
vs History
1
vs Industry
19
Median 3Y
23.2
Median 5Y
23.7
Industry
21.4
Forward
20
vs History
17
vs Industry
15
Median 3Y
26.6
Median 5Y
24.8
Industry
16.8
vs History
17
vs Industry
19
Median 3Y
26.1
Median 5Y
28.1
Industry
23.1
vs History
4
vs Industry
8
Median 3Y
7.3
Median 5Y
7.2
Industry
2.3
vs History
1
vs Industry
24
Median 3Y
4.8
Median 5Y
4.6
Industry
2.9
Forward
5.2
vs History
1
vs Industry
25
Median 3Y
8
Median 5Y
8
Industry
5.5
vs History
3
vs Industry
19
Median 3Y
18
Median 5Y
18.1
Industry
13.3
Forward
14.4
vs History
3
vs Industry
22
Median 3Y
18.2
Median 5Y
18.6
Industry
16.5
Forward
15.8
vs History
17
vs Industry
16
Median 3Y
26.4
Median 5Y
24.2
Industry
16
vs History
17
vs Industry
13
Median 3Y
37.3
Median 5Y
36.9
Industry
18.9
vs History
3
vs Industry
13
Median 3Y
5.3
Median 5Y
5.5
Industry
2

Multiples Across Competitors

ORINF Competitors Multiples
Orion Oyj Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FI
Orion Oyj
OTC:ORINF
9.9B USD 6.1 31.7 24.8 24.8
US
Eli Lilly and Co
NYSE:LLY
982.2B USD 16.5 53.3 35.8 38.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
526.1B USD 5.7 20.9 17.1 22.2
CH
Roche Holding AG
SIX:ROG
277.8B CHF 4.5 29.5 12.5 14.6
UK
AstraZeneca PLC
LSE:AZN
217.9B GBP 5 31 108.8 159.2
CH
Novartis AG
SIX:NOVN
221.8B CHF 4.9 19.2 12.1 15.7
US
Merck & Co Inc
NYSE:MRK
270.7B USD 4.2 14.2 10.1 12
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.5 16.6 11.6 13.4
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
145.8B USD 2.3 14.8 7.5 10.3
P/E Multiple
Earnings Growth PEG
FI
O
Orion Oyj
OTC:ORINF
Average P/E: 25.7
31.7
18%
1.8
US
Eli Lilly and Co
NYSE:LLY
53.3
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
29.5
29%
1
UK
AstraZeneca PLC
LSE:AZN
31
37%
0.8
CH
Novartis AG
SIX:NOVN
19.2
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
16.6
3%
5.5
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.8
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FI
O
Orion Oyj
OTC:ORINF
Average EV/EBITDA: 402.3
24.8
11%
2.3
US
Eli Lilly and Co
NYSE:LLY
35.8
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
17.1
9%
1.9
CH
Roche Holding AG
SIX:ROG
12.5
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
CH
Novartis AG
SIX:NOVN
12.1
6%
2
US
Merck & Co Inc
NYSE:MRK
10.1
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
11.6
1%
11.6
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FI
O
Orion Oyj
OTC:ORINF
Average EV/EBIT: 1 714.7
24.8
14%
1.8
US
Eli Lilly and Co
NYSE:LLY
38.4
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
22.2
15%
1.5
CH
Roche Holding AG
SIX:ROG
14.6
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
CH
Novartis AG
SIX:NOVN
15.7
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
13.4
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
7%
1.5